Zomedica Corp.: capital expenditure payments
Capital expenditure payments for Zomedica Corp. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All Zomedica Corp. financial histories
What this measure means
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
Exact concept: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2016-01-01 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | 567,000 | USD | 2026-03-16 | 10-K · 0001104659-26-028450 |
| 2024-01-01 | 2024-12-31 | 5,212,000 | USD | 2026-03-16 | 10-K · 0001104659-26-028450 |
| 2023-01-01 | 2023-12-31 | 11,339,000 | USD | 2025-03-13 | 10-K · 0001558370-25-002904 |
| 2022-01-01 | 2022-12-31 | 787,000 | USD | 2024-04-01 | 10-K · 0001558370-24-004517 |
| 2021-01-01 | 2021-12-31 | 147,000 | USD | 2023-03-15 | 10-K · 0001558370-23-003899 |
| 2020-01-01 | 2020-12-31 | 14,850 | USD | 2022-03-01 | 10-K · 0001654954-22-002343 |
| 2019-01-01 | 2019-12-31 | 155,513 | USD | 2021-02-26 | 10-K · 0001171843-21-001378 |
| 2018-01-01 | 2018-12-31 | 627,997 | USD | 2020-02-26 | 10-K · 0001171843-20-001304 |
| 2017-01-01 | 2017-12-31 | 171,736 | USD | 2019-03-14 | 10-K/A · 0001171843-19-001710 |
| 2016-01-01 | 2016-12-31 | 231,604 | USD | 2018-02-28 | 10-K · 0001171843-18-001549 |
Related financial histories
- Zomedica Corp.: total assets
- Zomedica Corp.: total liabilities
- Zomedica Corp.: stockholders equity
- Zomedica Corp.: cash and cash equivalents
- Zomedica Corp.: net income or loss
- Zomedica Corp.: operating cash flow
- Zomedica Corp.: contract revenue excluding tax
- Zomedica Corp.: financing cash flow
- Zomedica Corp.: investing cash flow
- Zomedica Corp.: retained earnings or deficit
- Zomedica Corp.: basic weighted-average shares
- Zomedica Corp.: diluted weighted-average shares
- Zomedica Corp.: basic earnings per share
- Zomedica Corp.: diluted earnings per share
- Zomedica Corp.: income tax expense or benefit
- Zomedica Corp.: net property, plant and equipment
- Zomedica Corp.: share-based compensation expense
- Zomedica Corp.: operating income or loss
- Zomedica Corp.: current assets
- Zomedica Corp.: interest expense
- Zomedica Corp.: current liabilities
- Zomedica Corp.: current accounts payable
- Zomedica Corp.: goodwill carrying amount
- Zomedica Corp.: net finite-lived intangible assets
- Zomedica Corp.: net current accounts receivable
- Zomedica Corp.: net inventory
- Zomedica Corp.: gross profit
- Zomedica Corp.: cost of revenue
- Zomedica Corp.: selling, general and administrative expense
- Zomedica Corp.: research and development expense
Inspect the source
- Entity
- Zomedica Corp. / CIK 0001684144
- Captured
- 2026-09-21T17:25:07.966Z
- SEC response SHA-256
3dc2d438fa7ab1081d7ffeb1a9da43a23bf7f569d0ff0f4a0b25445c59a01409
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001684144.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))